Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by 1wascallywabbit on Sep 04, 2014 9:05pm

Rx

just look at the 5 yr chart for v-rx. In 2017 just 3 short years from now, bnc chart will look just like it ! LOL.
Comment by 1wascallywabbit on Sep 07, 2014 11:37am
Here is the chart of BIOSYENT INC for anyone that could not get to it; Looks like about $0.25 to $10+ in 3 years. That little spike at the 2011 mark - the was BNCs spike to $0.43 a few weeks back, and we too have drifted back close to the lows. Get ready to take your major position here in the high teens, and tighten your seatbelts! Dream on Baby! LOL Scale: Type:
Comment by NoNukNuk on Sep 07, 2014 10:30pm
we are not biosyent, we are more like biostench.  Maybe we are even bio-hazard.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities